Search research articles
Contact Us
Filters
Showing results (191-200 of 244) with videos related to
Page
of 25
Sort By:
British Journal of Pharmacology
|
July 3, 2004
The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects
Dominique Kavvadias, Philipp Sand, Kuresh A Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 20, 2023
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
April 13, 2010
Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: a pilot post-mortem study
Tanja Maria Michel, Wieland Gsell, Jürgen Geuder, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort
Andreas Reif, Edna Grünblatt, Sabine Herterich, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 28, 2012
Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD
Johannes Thome, Ann-Christine Ehlis, Andreas J Fallgatter, et al.
Dialogues in Clinical Neuroscience
|
September 15, 2005
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants
Pierre Baumann, Sven Ulrich, Gabriel Eckermann, et al.
Journal of Psychiatric Research
|
July 8, 2008
Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study
Edna Grünblatt, Sonja Zehetmayer, Jasmin Bartl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 11, 2025
Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats
Ana Knezovic, Michael Hosch, Catharina Sophia Hamann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2025
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression
Peter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Journal of Neurology
|
February 9, 2010
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease
Oliver Riedel, Jens Klotsche, Annika Spottke, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 244) with videos related to
Sort By:
Page
of 25
British Journal of Pharmacology
|
July 3, 2004
The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects
Dominique Kavvadias, Philipp Sand, Kuresh A Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 20, 2023
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
April 13, 2010
Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: a pilot post-mortem study
Tanja Maria Michel, Wieland Gsell, Jürgen Geuder, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort
Andreas Reif, Edna Grünblatt, Sabine Herterich, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 28, 2012
Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD
Johannes Thome, Ann-Christine Ehlis, Andreas J Fallgatter, et al.
Dialogues in Clinical Neuroscience
|
September 15, 2005
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants
Pierre Baumann, Sven Ulrich, Gabriel Eckermann, et al.
Journal of Psychiatric Research
|
July 8, 2008
Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study
Edna Grünblatt, Sonja Zehetmayer, Jasmin Bartl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 11, 2025
Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats
Ana Knezovic, Michael Hosch, Catharina Sophia Hamann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2025
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression
Peter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Journal of Neurology
|
February 9, 2010
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease
Oliver Riedel, Jens Klotsche, Annika Spottke, et al.
Page
of 25